[go: up one dir, main page]

GB201300563D0 - Identification of patients for breast cancer therapy - Google Patents

Identification of patients for breast cancer therapy

Info

Publication number
GB201300563D0
GB201300563D0 GBGB1300563.2A GB201300563A GB201300563D0 GB 201300563 D0 GB201300563 D0 GB 201300563D0 GB 201300563 A GB201300563 A GB 201300563A GB 201300563 D0 GB201300563 D0 GB 201300563D0
Authority
GB
United Kingdom
Prior art keywords
patients
identification
breast cancer
cancer therapy
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1300563.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nottingham Trent University
Original Assignee
Nottingham Trent University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nottingham Trent University filed Critical Nottingham Trent University
Priority to GBGB1300563.2A priority Critical patent/GB201300563D0/en
Publication of GB201300563D0 publication Critical patent/GB201300563D0/en
Priority to PCT/GB2014/050090 priority patent/WO2014108707A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G01N33/57515—
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB1300563.2A 2013-01-14 2013-01-14 Identification of patients for breast cancer therapy Ceased GB201300563D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1300563.2A GB201300563D0 (en) 2013-01-14 2013-01-14 Identification of patients for breast cancer therapy
PCT/GB2014/050090 WO2014108707A1 (en) 2013-01-14 2014-01-14 Identification of patients for breast cancer theraphy using t128 family members as markers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1300563.2A GB201300563D0 (en) 2013-01-14 2013-01-14 Identification of patients for breast cancer therapy

Publications (1)

Publication Number Publication Date
GB201300563D0 true GB201300563D0 (en) 2013-02-27

Family

ID=47757898

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1300563.2A Ceased GB201300563D0 (en) 2013-01-14 2013-01-14 Identification of patients for breast cancer therapy

Country Status (2)

Country Link
GB (1) GB201300563D0 (en)
WO (1) WO2014108707A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0407587D0 (en) 2004-04-02 2004-05-05 Univ Nottingham Trent Cancer associated antigens

Also Published As

Publication number Publication date
WO2014108707A1 (en) 2014-07-17

Similar Documents

Publication Publication Date Title
SG11201501653RA (en) Methods for the treatment of locally advanced breast cancer
LT3033086T (en) Combination therapy for the treatment of cancer
IL241232B (en) Compounds for treatment of cancer
EP2968348A4 (en) Compounds for treatment of cancer
IL261659A (en) Treatment of brain cancer
GB201322725D0 (en) Cancer therapy
LT2804599T (en) Combination therapy for the treatment of cancer
PT3458610T (en) Therapeutic treatment of breast cancer based on c-maf status
LT3077544T (en) Rationale-based design of a targeted therapy for cancer
SG10201913730RA (en) Cancer therapy
PL3089749T3 (en) Combined preparations for the treatment of cancer
EP2903644A4 (en) Treatment of cancer
SG11201507847UA (en) Cancer therapy
PL3062790T3 (en) Pharmaceutical combinations for the treatment of cancer
IL258671A (en) Therapeutic agent for breast cancer
GB201217892D0 (en) Treatment of cancer
GB201403083D0 (en) Treatment of cancer
EP2961412A4 (en) Cancer therapy
GB201300563D0 (en) Identification of patients for breast cancer therapy
PL3016948T3 (en) 2-acylaminothiazoles for the treatment of cancer
GB201217890D0 (en) Treatment of cancer
GB201200262D0 (en) Therapy of breast cancer
GB201322347D0 (en) Treatment of cancer
GB201318742D0 (en) Treatment of cancer
GB201308529D0 (en) Treatment of cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)